The basal ganglia are a set of deep forebrain and midbrain nuclei — striatum, globus pallidus, subthalamic nucleus, substantia nigra — wired into loops with cortex and thalamus that select which actions to release and which to suppress. Their direct pathway says "go," the indirect says "no-go," and dopamine from the substantia nigra biases the balance, also teaching which actions earn reward. Their circuit diseases are some of neurology's most famous: Parkinson's (too little go), Huntington's (too little no-go).
Location
Deep to the cortex, lateral to the thalamus; nigral component in the midbrain
Striatum is the input stage; GPi and SNr are the output stage, tonically inhibiting the thalamus; GPe and STN form the indirect pathway's relay — a disinhibitory architecture.
Parallel loops run through segregated territories: motor (putamen), associative (caudate), limbic (ventral striatum/nucleus accumbens) — one circuit design, several functions.
The hyperdirect pathway (cortex → STN) provides a fast stop signal that tasks requiring inhibition recruit.
Circuitry & Connections
Direct pathway: D1-receptor striatal neurons inhibit GPi/SNr, releasing thalamus — movement facilitation.
Indirect pathway: D2-receptor neurons inhibit GPe, freeing STN to excite GPi — movement suppression; dopamine excites the first and inhibits the second, both pro-movement.
Reward prediction-error signals from midbrain dopamine (Schultz's monkey recordings) train striatal synapses — the reinforcement-learning circuit of computational neuroscience, with the VTA as the limbic dopamine source.
Function
Action selection: releasing one motor program while holding competitors — the "brake-release" model of basal-ganglia output.
Habit and skill: dorsal striatum consolidates repeated action sequences into automatic habits — chunking.
Motivation: ventral loops link value to vigor — how much effort is worth spending.
Clinical Relevance
Parkinson's disease: SNc dopamine loss — bradykinesia, rigidity, tremor; levodopa replaces dopamine, DBS of STN or GPi rebalances the circuit.
Huntington's disease: indirect-pathway striatal neuron loss first — chorea, then cognitive and psychiatric decline.